Phase I clinical trial of peptide vaccine for advanced gastric and colorectal cancer

Phase I clinical trial of peptide vaccine for advanced gastric and colorectal cancer - Phase I clinical trial of peptide vaccine for advanced gastric and colorectal cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004572

Enrollment

Registered

2010-11-17

Start date

2009-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced or recurrent gastric and colorectal cancer

Interventions

peptide vaccine therapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Performance Status 0-1 Refractory to standard therapy

Exclusion criteria

Exclusion criteria: Pregnancy Uncontrolled infection Patients with serious concomitant disease

Design outcomes

Primary

Measure	Time frame
We confirm the safety of the peptide vaccine against gastric and colorectal cancer patient.	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026